Atlas Trials

Trabectedin and Irinotecan for Refractory Pediatric Sarcomas

Clinical trial NCT02509234 · UNKNOWN

Trial details

NCT number
NCT02509234
Sponsor
Technical University of Munich
Status
UNKNOWN
Study type
OBSERVATIONAL
Recurrent Childhood Soft Tissue SarcomaRecurrent Ewing SarcomaRecurrent Rhabdomyosarcoma
Start date
2014-02-01
Primary completion
2016-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.